Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production BJ Johnson, TTT Le, CA Dobbin, T Banovic, CB Howard, FML Flores, ... Journal of Biological Chemistry 280 (6), 4037-4047, 2005 | 190 | 2005 |
Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP J Mo, JP Boyle, CB Howard, TP Monie, BK Davis, JA Duncan Journal of Biological Chemistry 287 (27), 23057-23067, 2012 | 184 | 2012 |
Recent advances in the generation of antibody–nanomaterial conjugates AJ Sivaram, A Wardiana, CB Howard, SM Mahler, KJ Thurecht Advanced healthcare materials 7 (1), 1700607, 2018 | 111 | 2018 |
Targeting membrane proteins for antibody discovery using phage display ML Jones, MA Alfaleh, S Kumble, S Zhang, GW Osborne, M Yeh, N Arora, ... Scientific reports 6 (1), 26240, 2016 | 95 | 2016 |
Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cells J Tang, L Li, CB Howard, SM Mahler, L Huang, ZP Xu Journal of materials chemistry B 3 (33), 6805-6812, 2015 | 91 | 2015 |
Targeted camptothecin delivery via silicon nanoparticles reduces breast cancer metastasis M Landgraf, CA Lahr, I Kaur, A Shafiee, A Sanchez-Herrero, PW Janowicz, ... Biomaterials 240, 119791, 2020 | 87 | 2020 |
Identification and Minisequencing-Based Discrimination of SHV β-Lactamases in Nosocomial Infection-Associated Klebsiella pneumoniae in Brisbane, Australia C Howard, A Van Daal, G Kelly, J Schooneveldt, G Nimmo, PM Giffard Antimicrobial agents and chemotherapy 46 (3), 659-664, 2002 | 80 | 2002 |
Enhanced uptake of potassium or glycine betaine or export of cyclic-di-AMP restores osmoresistance in a high cyclic-di-AMP Lactococcus lactis mutant HT Pham, NTH Nhiep, TNM Vu, TAN Huynh, Y Zhu, ALD Huynh, ... PLoS genetics 14 (8), e1007574, 2018 | 75 | 2018 |
Multiplexed SERS detection of soluble cancer protein biomarkers with gold–silver alloy nanoboxes and nanoyeast single-chain variable fragments J Li, J Wang, YS Grewal, CB Howard, LJ Raftery, S Mahler, Y Wang, ... Analytical chemistry 90 (17), 10377-10384, 2018 | 74 | 2018 |
Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands J Tang, CB Howard, SM Mahler, KJ Thurecht, L Huang, ZP Xu Nanoscale 10 (9), 4258-4266, 2018 | 71 | 2018 |
Overcoming instability of antibody‐nanomaterial conjugates: next generation targeted nanomedicines using bispecific antibodies CB Howard, N Fletcher, ZH Houston, AV Fuchs, NRB Boase, JD Simpson, ... Advanced healthcare materials 5 (16), 2055-2068, 2016 | 63 | 2016 |
A SERS microfluidic platform for targeting multiple soluble immune checkpoints KK Reza, AAI Sina, A Wuethrich, YS Grewal, CB Howard, D Korbie, ... Biosensors and Bioelectronics 126, 178-186, 2019 | 57 | 2019 |
Strategies for selecting membrane protein-specific antibodies using phage display with cell-based panning MA Alfaleh, ML Jones, CB Howard, SM Mahler Antibodies 6 (3), 10, 2017 | 50 | 2017 |
Nanocell targeting using engineered bispecific antibodies K Taylor, CB Howard, ML Jones, I Sedliarou, J MacDiarmid, H Brahmbhatt, ... MAbs 7 (1), 53-65, 2015 | 45 | 2015 |
Modulating targeting of poly (ethylene glycol) particles to tumor cells using bispecific antibodies J Cui, Y Ju, ZH Houston, JJ Glass, NL Fletcher, S Alcantara, Q Dai, ... Advanced healthcare materials 8 (9), 1801607, 2019 | 44 | 2019 |
Understanding the uptake of nanomedicines at different stages of brain cancer using a modular nanocarrier platform and precision bispecific antibodies ZH Houston, J Bunt, KS Chen, S Puttick, CB Howard, NL Fletcher, ... ACS central science 6 (5), 727-738, 2020 | 43 | 2020 |
Controlling the biological fate of micellar nanoparticles: Balancing stealth and targeting AJ Sivaram, A Wardiana, S Alcantara, SE Sonderegger, NL Fletcher, ... ACS nano 14 (10), 13739-13753, 2020 | 37 | 2020 |
Multifunctional lipid-coated calcium phosphate nanoplatforms for complete inhibition of large triple negative breast cancer via targeted combined therapy J Tang, B Li, CB Howard, SM Mahler, KJ Thurecht, Y Wu, L Huang, ZP Xu Biomaterials 216, 119232, 2019 | 32 | 2019 |
Targeting the undruggable: emerging technologies in antibody delivery against intracellular targets S Niamsuphap, C Fercher, S Kumble, P Huda, SM Mahler, CB Howard Expert Opinion on Drug Delivery 17 (9), 1189-1211, 2020 | 28 | 2020 |
Bispecific antibody-functionalized upconversion nanoprobe H He, CB Howard, Y Chen, S Wen, G Lin, J Zhou, KJ Thurecht, D Jin Analytical chemistry 90 (5), 3024-3029, 2018 | 28 | 2018 |